141 related articles for article (PubMed ID: 10961665)
1. Glatiramer acetate (copolymer-1)-specific, human T cell lines: cytokine profile and suppression of T cell lines reactive against myelin basic protein.
Dabbert D; Rösner S; Krämer M; Schöll U; Tumani H; Mäder M; Weber F
Neurosci Lett; 2000 Aug; 289(3):205-8. PubMed ID: 10961665
[TBL] [Abstract][Full Text] [Related]
2. Characterization of T cell lines derived from glatiramer-acetate-treated multiple sclerosis patients.
Qin Y; Zhang DQ; Prat A; Pouly S; Antel J
J Neuroimmunol; 2000 Aug; 108(1-2):201-6. PubMed ID: 10900354
[TBL] [Abstract][Full Text] [Related]
3. Additive effects of copolymer-1 and interferon beta-1b on the immune response to myelin basic protein.
Milo R; Panitch H
J Neuroimmunol; 1995 Sep; 61(2):185-93. PubMed ID: 7593554
[TBL] [Abstract][Full Text] [Related]
4. Glatiramer acetate induces a Th2-biased response and crossreactivity with myelin basic protein in patients with MS.
Chen M; Gran B; Costello K; Johnson K; Martin R; Dhib-Jalbut S
Mult Scler; 2001 Aug; 7(4):209-19. PubMed ID: 11548979
[TBL] [Abstract][Full Text] [Related]
5. Cytokine secretion of myelin basic protein reactive T cells in patients with multiple sclerosis.
Windhagen A; Anderson DE; Carrizosa A; Balashov K; Weiner HL; Hafler DA
J Neuroimmunol; 1998 Nov; 91(1-2):1-9. PubMed ID: 9846813
[TBL] [Abstract][Full Text] [Related]
6. Blocking effects of serum reactive antibodies induced by glatiramer acetate treatment in multiple sclerosis.
Salama HH; Hong J; Zang YC; El-Mongui A; Zhang J
Brain; 2003 Dec; 126(Pt 12):2638-47. PubMed ID: 12937077
[TBL] [Abstract][Full Text] [Related]
7. Glatiramer acetate-reactive peripheral blood mononuclear cells respond to multiple myelin antigens with a Th2-biased phenotype.
Dhib-Jalbut S; Chen M; Said A; Zhan M; Johnson KP; Martin R
J Neuroimmunol; 2003 Jul; 140(1-2):163-71. PubMed ID: 12864985
[TBL] [Abstract][Full Text] [Related]
8. Glatiramer acetate-specific human CD8(+) T cells: increased IL-4 production in multiple sclerosis is reduced by glatiramer acetate treatment.
Dressel A; Vogelgesang A; Brinkmeier H; Mäder M; Weber F
J Neuroimmunol; 2006 Dec; 181(1-2):133-40. PubMed ID: 17084909
[TBL] [Abstract][Full Text] [Related]
9. Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy. Brain-derived neurotrophic factor.
Ziemssen T; Kümpfel T; Klinkert WE; Neuhaus O; Hohlfeld R
Brain; 2002 Nov; 125(Pt 11):2381-91. PubMed ID: 12390966
[TBL] [Abstract][Full Text] [Related]
10. Effect of combined IFNbeta-1a and glatiramer acetate therapy on GA-specific T-cell responses in multiple sclerosis.
Dhib-Jalbut S; Chen M; Henschel K; Ford D; Costello K; Panitch H
Mult Scler; 2002 Dec; 8(6):485-91. PubMed ID: 12474988
[TBL] [Abstract][Full Text] [Related]
11. In vitro evidence that subcutaneous administration of glatiramer acetate induces hyporesponsive T cells in patients with multiple sclerosis.
Schmied M; Duda PW; Krieger JI; Trollmo C; Hafler DA
Clin Immunol; 2003 Mar; 106(3):163-74. PubMed ID: 12706402
[TBL] [Abstract][Full Text] [Related]
12. Cytokine secretion profile of myelin basic protein-specific T cells in multiple sclerosis.
Rohowsky-Kochan C; Molinaro D; Cook SD
Mult Scler; 2000 Apr; 6(2):69-77. PubMed ID: 10773850
[TBL] [Abstract][Full Text] [Related]
13. Copolymer 1 induces T cells of the T helper type 2 that crossreact with myelin basic protein and suppress experimental autoimmune encephalomyelitis.
Aharoni R; Teitelbaum D; Sela M; Arnon R
Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10821-6. PubMed ID: 9380718
[TBL] [Abstract][Full Text] [Related]
14. Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis.
Duda PW; Schmied MC; Cook SL; Krieger JI; Hafler DA
J Clin Invest; 2000 Apr; 105(7):967-76. PubMed ID: 10749576
[TBL] [Abstract][Full Text] [Related]
15. Multiple sclerosis: glatiramer acetate induces anti-inflammatory T cells in the cerebrospinal fluid.
Hestvik AL; Skorstad G; Price DA; Vartdal F; Holmoy T
Mult Scler; 2008 Jul; 14(6):749-58. PubMed ID: 18611988
[TBL] [Abstract][Full Text] [Related]
16. Failure of glatiramer acetate to modify the peripheral T cell repertoire of relapsing-remitting multiple sclerosis patients.
Berthelot L; Miqueu P; Pettré S; Guillet M; Moynard J; Wiertlewski S; Lefrère F; Brouard S; Soulillou JP; Laplaud DA
Clin Immunol; 2010 Apr; 135(1):33-42. PubMed ID: 20116333
[TBL] [Abstract][Full Text] [Related]
17. Multiple sclerosis: comparison of the human T-cell response to S100 beta and myelin basic protein reveals parallels to rat experimental autoimmune panencephalitis.
Schmidt S; Linington C; Zipp F; Sotgiu S; de Waal Malefyt R; Wekerle H; Hohlfeld R
Brain; 1997 Aug; 120 ( Pt 8)():1437-45. PubMed ID: 9278633
[TBL] [Abstract][Full Text] [Related]
18. Glatiramer acetate (GA) induces IL-13/IL-5 secretion in naive T cells.
Wiesemann E; Klatt J; Sönmez D; Blasczyk R; Heidenreich F; Windhagen A
J Neuroimmunol; 2001 Sep; 119(1):137-44. PubMed ID: 11525811
[TBL] [Abstract][Full Text] [Related]
19. Cytokine phenotype of human autoreactive T cell clones specific for the immunodominant myelin basic protein peptide (83-99).
Hemmer B; Vergelli M; Calabresi P; Huang T; McFarland HF; Martin R
J Neurosci Res; 1996 Sep; 45(6):852-62. PubMed ID: 8892097
[TBL] [Abstract][Full Text] [Related]
20. Elispot assay detection of cytokine secretion in multiple sclerosis patients treated with interferon-beta1a or glatiramer acetate compared with untreated patients.
Jansson A; Ernerudh J; Kvarnström M; Ekerfelt C; Vrethem M
Mult Scler; 2003 Oct; 9(5):440-5. PubMed ID: 14582766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
